Form 4: CVS Health Director Larry Robbins Reports Share Transactions

CVS Health director Larry Robbins reported transactions involving common stock, cash-settled swaps, and deferred stock units.

Summary

• Larry Robbins, a director at CVS Health, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• The filing includes transactions involving common stock held indirectly through Glenview Investment Funds, cash-settled swaps, and deferred stock units.
• Robbins indirectly holds 11,946,799 shares of CVS common stock through Glenview Investment Funds.
• He also indirectly holds cash-settled swaps referencing 378,000 shares of CVS common stock through Glenview Offshore Opportunity Master Fund.
• Additionally, Robbins acquired 2,933.4501 deferred stock units valued at $57.1 each, which will convert to common stock upon his retirement from the board.

Sentiment

Score: 7

Explanation: The document is a routine disclosure of insider transactions, which is neither positive nor negative. The acquisition of deferred stock units is a positive sign of alignment with the company's long-term performance.

Positives

• The acquisition of deferred stock units aligns the director's interests with the long-term performance of the company.
• The deferred stock units are valued at the market price, reflecting current market conditions.

Future Outlook

The deferred stock units will convert to common stock upon Larry Robbins' retirement from the board.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies like CVS Health. It provides transparency into the holdings and transactions of key personnel.

Comparison to Industry Standards

• Form 4 filings are standard practice for directors and officers of publicly traded companies in the US, as mandated by the SEC.
• The reporting of indirect holdings through investment funds is also a common practice for individuals with significant financial interests.
• The use of deferred stock units as part of director compensation is a typical practice among large corporations, aligning director interests with long-term shareholder value.

Stakeholder Impact

• The transactions reported in the Form 4 provide transparency to shareholders regarding the holdings of a key director.
• The acquisition of deferred stock units aligns the director's interests with the long-term performance of the company, which is beneficial for shareholders.

Key Dates

Keywords

CVS Health, Larry Robbins, Form 4, Beneficial Ownership, Common Stock, Cash-Settled Swaps, Deferred Stock Units, Glenview Investment Funds, Director Compensation